Mason, Ohio-based Atricure Inc. has inked an agreement to buy Redwood City, Calif.-based Sentreheart Inc., which has developed and markets the Lariat percutaneous, epicardial suture delivery device for soft tissue closure. The deal includes an upfront payment of $40 million in cash and stock, plus additional payments related to regulatory and reimbursement milestones over the next several years. Read More
